CA9 and nonpapillary renal cell carcinoma: A microfluidic technology known as exclusion‐based sample preparation (ESP) demonstrating high capture efficiency of low‐affinity targets was utilized to capture ccRCC CTCs with both CAIX and EpCAM [35].